Genetic Engineering & Biotechnology News

JUL 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/841647

Contents of this Issue

Navigation

Page 42 of 45

For more information, visit our website (GENengnews.com), click on New Products, and search through our comprehensive new products database. New Products Genetic Engineering & Biotechnology News | GENengnews.com | JULY 2017 | 41 People Subscribe Clinical OMICs extends GEN's comprehensive coverage to the clinic by focusing on the application of revolutionary molecular technologies in medical practice. Topics covered include personalized and precision medicine, next-gen sequencing, bioinformatics, reimbursement, and bioethics. To see past issues, recent news, and subscribe, go to: clinicalomics.com GEN'S NEW ePUB Molecular Diagnostics in Personalized Medicine Advertiser Index Owlstone Medical estab- lished a scientific advisory board with Bruce Ponder, Ph.D. He is a professor emeritus at the University of Cambridge, and was awarded the CRUK lifetime achieve- ment prize. In 2008, he was knighted for his services in medicine. Profile Aldevron hired Henry Hebel as COO. Hebel was most recently vice president, operations, at Aeglea Biotherapeutics. Before that, he was vice president of drug development for Terapio. Earlier in his career, he was COO of VGXI (previously ADViSYS). Profile Illumina promoted Mark Van Oene to chief commercial officer. Van Oene was previously senior vice president of the Americas. He joined Illumina as a regional account manager for Canada in 2006. Before that, he was director, Ellipsis Biotherapeutics. Profile Reprints Karen Ballen 914-740-2194 reprints@GENengnews.com GEN offers reprints of individual articles — in printed or electronic form — to increase awareness of your product or company. Order today! Advanced Analytical . . . . . . . . . . . . . . . . 20 Amerisource Bergen . . . . . . . . . . . . . . . . 17 Applied Biological Materials . . . . . . . . . 29 Bachem. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 BioSpec . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 Cambridge Healthtech Institute . . . . . 26 Clinical OMICs . . . . . . . . . . . . . . . . . . . . . . 41 Clinical OMICs/N-of-One webinar . . . . 35 Corning. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 Eppendorf . . . . . . . . . . . . . . . . . . . . . . . . . . 25 GEN eXpertTech . . . . . . . . . . . . . . . . . . . . 33 GEN/ProteinSimple webinar . . . . . . . . . 43 GEN/Unchained Labs webinar . . . . . . . 31 Integra Biosciences . . . . . . . . . . . . . . . . . 13 Lonza . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 MaxCyte . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 Merck Millipore . . . . . . . . . . . . . . . . . . . 5,15 MilliporeSigma. . . . . . . . . . . . . . . . . . . . 5,15 OriGene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Panasonic . . . . . . . . . . . . . . . . . . . . . . . . . . 21 PerkinElmer . . . . . . . . . . . . . . . . . . . . . . . . . 12 PolyPeptide Labs . . . . . . . . . . . . . . . . . . . . 27 PreSens Precision Sensing . . . . . . . . . . . 26 Promega . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 RayBiotech . . . . . . . . . . . . . . . . . . . . . . . . . 44 Roche Diagnostics . . . . . . . . . . . . . . . . . . 19 Roche Diagnostics . . . . . . . . . . . Cover Tip Sierra Sensors . . . . . . . . . . . . . . . . . . . . . . . . 2 Sonntek . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 CORRECTION On pg. 7 of the June 1 issue of GEN, please note that the correct phone number for Stemonix, the corporate profile, should have been listed as 855-783-6669. Casebia Therapeutics welcomed Ellen Ridge as senior vice president, op- erations; Abraham Scaria, Ph.D., as vice president, opthalmology; and Andrew M. Scharenberg, M.D., as CSO and vice president, hematology. SciBase elected Thomas Taapken, Ph.D., Diano Ferro, and Thomas Eklund to its board of directors. Yposkesi elected Jean-François Chaubard, Catherine Jomary, Ph.D., and Dennis Rigolet to its executive committee. Dragonfly Therapeutics hired Ann Cheung, Ph.D., as head of biology, and appointed Adelheid Cerwenka, Ph.D., to its advisory board. Asterias Biotherapteutics hired Michael Mulroy as president and CEO, and promoted Katy Spink, Ph.D., to executive vice president and COO. Stephen Peroutka, M.D., Ph.D., joined Pharmaceuti- cal Product Development as vice president, global product development and therapeutic head for neuroscience. Juno Therapeutics elected Jay Flatley to its board of directors. Volker Knappertz, M.D., is the new CMO of GW Pharmaceuticals. Bioverativ appointed Geno J. Germano to its board of directors. Sarah Noonberg, M.D., Ph.D., is the new CMO at Prothena. John Marshall, M.D., joined Caris Life Sciences as CMO. Actinium Pharma- ceuticals appointed Richard Stone, M.D., to its scientific advisory board. Don Hardison joined Biotheranostics as CEO. Classified Mini Bead Beater 24 Tissue Tearor Mini Bead Beater 16 Mini Bead Beater 96 Bio Pulverizer Cryo Cup Bio Vortexer 800.617.3363 TISSUE DISPERSER Micro Mincer

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - JUL 2017